本文へ移動
cccskills
無料GitHub で公開

es-cushing-unilateral-resection-experienced-surgeon

This skill recommends unilateral resection by an experienced adrenal surgeon for all cases of benign unilateral disease causing Cushing's syndrome. Trigger when a CS patient has a unilateral adrenal lesion confirmed benign via imaging and biochemical assessment.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.8 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Unilateral Resection by Experienced Adrenal Surgeon for Benign Unilateral Disease

STEP 1 — Gather Information

Collect confirmation of overt Cushing's syndrome (elevated UFC, loss of diurnal cortisol rhythm, or abnormal dexamethasone suppression test), adrenal imaging showing unilateral lesion, and biochemical/imaging evidence of benign unilateral etiology (suppressed ACTH, contralateral adrenal normal, imaging features of adenoma e.g., CT density <10 HU). If confirmed, proceed to step 2; otherwise, consider alternative first-line treatments.

STEP 2 — Rule In / Rule Out

Rule In: Unilateral benign adrenal lesion confirmed (suppressed ACTH, unilateral lesion with benign imaging features) -> proceed to step 3. Rule Out: Not unilateral benign (bilateral disease, malignant features, or unconfirmed) -> do not apply this skill; consider other first-line options (e.g., TSS for ACTH-dependent CS, medical therapy or bilateral adrenalectomy for bilateral disease).

STEP 3 — Classify or Stratify

Confirm patient is a surgical candidate and that an experienced adrenal surgeon is available (e.g., surgeon with expertise in adrenal surgery, typically >20 adrenalectomies/year). If yes, proceed to step 4; else, consider alternatives (e.g., medical therapy or referral to experienced center).

STEP 4 — Decide

Recommend unilateral adrenalectomy by the experienced adrenal surgeon.

Clinical Guardrails / Mimics / Pitfalls

Do not proceed if malignancy is suspected (irregular margins, invasion, CT density >20 HU, or hormonal profile suggestive of carcinoma). Do not proceed if bilateral disease is suspected (e.g., in ACTH-independent CS, contralateral adrenal nodularity or biochemical evidence of bilateral autonomy). Pitfall: mistaking unilateral lesion in early BMAH as solitary adenoma — always image both adrenals and consider biochemical tests for bilateral autonomy. Ensure surgeon experience to avoid higher complication rates.

Concrete Clinical Example

A 50-year-old man with hypertension, diabetes, and easy bruising has elevated UFC (2x ULN), loss of diurnal cortisol rhythm, and suppressed ACTH. CT shows a 2.0 cm right adrenal lesion with homogeneous low density (3 HU), consistent with lipid-rich adenoma; left adrenal normal. -> Recommend unilateral right adrenalectomy by an experienced adrenal surgeon.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2015, doi:10.1210/jc.2015-1818

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する